US Patent

US11369566 — Controlled release antimicrobial compositions and methods for the treatment of otic disorders

Formulation · Assigned to University of California San Diego UCSD · Expires 2029-04-21 · 3y remaining

Vulnerability score 63/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects controlled release compositions and methods for treating otic disorders with antimicrobial agents administered directly to the affected area.

USPTO Abstract

Disclosed herein are compositions and methods for the treatment of otic diseases or conditions with antimicrobial agent compositions and formulations administered locally to an individual afflicted with an otic disease or condition, through direct application of these compositions and formulations onto or via perfusion into the targeted auris structure(s).

Drugs covered by this patent

Patent Metadata

Patent number
US11369566
Jurisdiction
US
Classification
Formulation
Expires
2029-04-21
Drug substance claim
No
Drug product claim
Yes
Assignee
University of California San Diego UCSD
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.